Sankalp India Foundation is excited to announce the successful installation of a state-of-the-art blood irradiator at our facility, marking a significant advancement in the safety and effectiveness of bone marrow transplants (BMT).
We started the year strong! On the Cure side, we’re focused on keeping our program fully engaged throughout the year and planning the inauguration of our new unit in Ahmedabad.
Within Management, we’re restructuring to handle increased activity, addressing current challenges, and creating a mitigation plan.
On the Prevention front, we’ve tested over 15,000+ individuals in the first month, with plans to expand further.
Dreams can be powerful, but when combined with action, they become transformative. Sankalp, a visionary with an unwavering belief in the power of persistence, is the perfect blend of dreamer and doer.
Many women in India seek antenatal care late, with 1 in 6 starting after 18 weeks. Sankalp Labs has now secured registration to offer fetal genetic testing for thalassemia and sickle cell diseases, reducing wait times from weeks to just 3 days.
